SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-070959
Filing Date
2020-06-09
Accepted
2020-06-08 18:45:33
Documents
4
Period of Report
2020-06-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021988-1_8k.htm 8-K 36325
2 EXHIBIT 10.1 tm2021988d1_ex10-1.htm EX-10.1 21116
3 EXHIBIT 10.2 tm2021988d1_ex10-2.htm EX-10.2 17638
4 EXHIBIT 10.3 tm2021988d1_ex10-3.htm EX-10.3 29131
  Complete submission text file 0001104659-20-070959.txt   105550
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 20950431
SIC: 2834 Pharmaceutical Preparations